|
Volumn 44, Issue 6, 2012, Pages 1565-1567
|
Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCINEURIN INHIBITOR;
DOXORUBICIN;
EVEROLIMUS;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
RAPAMYCIN;
SORAFENIB;
ABDOMINAL WALL;
ADRENAL GLAND;
ADULT;
BONE;
CANCER EPIDEMIOLOGY;
CANCER PROGNOSIS;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CHEMOEMBOLIZATION;
CONFERENCE PAPER;
DISEASE SEVERITY;
FEMALE;
FOLLOW UP;
GANGLION;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER CELL CARCINOMA;
LIVER GRAFT;
LIVER TRANSPLANTATION;
LUNG;
MAJOR CLINICAL STUDY;
MALE;
MEDIASTINUM;
OVERALL SURVIVAL;
PERITONEUM;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
TUMOR GROWTH;
AGED;
CARCINOMA, HEPATOCELLULAR;
CHEMOEMBOLIZATION, THERAPEUTIC;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KAPLAN-MEIER ESTIMATE;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
MALE;
METASTASECTOMY;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
REOPERATION;
RISK ASSESSMENT;
RISK FACTORS;
SPAIN;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84864403896
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2012.05.007 Document Type: Conference Paper |
Times cited : (11)
|
References (9)
|